ライフサイエンスコーパス: virus envelope protein

1 the distal end of domain II of the West Nile virus envelope protein.

2 ed to domain III of the neuroadapted SPYF-MN virus envelope protein.

3 o sites within domains I and II of West Nile virus envelope protein.

4 onserved fusion and bc epitope of the dengue virus envelope protein.

5 ectors by pseudotyping with modified Sindbis virus envelope proteins.

6 in 'tail' formation mediated by the vaccinia virus envelope protein A36R, which utilizes two similarl

7 nant vaccinia virus vector expressing Friend virus envelope protein and a live attenuated Friend viru

8 was essential for interaction with the Lassa virus envelope protein and subsequent infection.

9 that both human and simian immunodeficiency virus envelope proteins can undergo endocytosis, the gE

10 glutinin (a "class I" fusogen) and West Nile virus envelope protein ("class II").

11 nally, the MMTV- and Moloney murine leukemia virus envelope proteins coimmunoprecipitated with TLR4 w

12 s or accessibility of the fusion loop on the virus envelope protein domain II (DII(FL)) in an ex vivo

13 ically distinct vaccine components, a dengue virus Envelope protein Domain III (EDIII) subunit antige

14 conformational changes in the heterodimeric virus envelope proteins E1 and E2.

15 The hepatitis C virus envelope protein, E2, is an endoplasmic reticulum

16 protomeric units of Moloney murine leukemia virus envelope protein (Env) are activated in relation t

17 Unlike most other virus envelope proteins, F is unusual since the target s

18 that contains truncated, recombinant, Dengue virus envelope protein from all four Dengue virus seroty

19 he 18-kDa leader peptide (LP18) of the foamy virus envelope protein (FVenv) as a new substrate for in

20 ctor in the presence of vesicular stomatitis virus envelope protein G (VSV-G) produced an insignifica

21 ve variants of HIV-1 (human immunodeficiency virus) envelope protein (gp120).

22 requirements for polyanion binding to dengue virus envelope protein has been established.

23 These modified Sindbis virus envelope proteins have mutations in their original

24 brane-spanning domain of the murine leukemia virus envelope protein in membrane fusion and its regula

25 han 142 in ecotropic Moloney murine leukemia virus envelope protein is essential to virus binding and

26 The human immunodeficiency virus envelope protein is the key element mediating entr

27 to the other category of baculovirus budded virus envelope proteins, Ld130, was present.

28 We hypothesized that dengue virus envelope protein mediates initial binding to targe

29 odies specific to the human immunodeficiency virus envelope protein, neutralizing activities, numbers

30 the WT, correlating with an accumulation of virus envelope proteins on the cell surface.

31 ional homologies between the Zika and Dengue viruses' envelope proteins raise the possibility that cr

32 -binding domain of Friend 57 murine leukemia virus envelope protein (RBD) has been proposed.

33 ng SLC35F2 the receptor of a feline leukemia virus envelope protein required for viral entry into euk

34 stallized soluble mutant forms of the dengue virus envelope protein (sE) that include portions of the

35 The Sindbis virus envelope protein spike is a hetero-oligomeric comp

36 f the NCI chemical database using the dengue virus envelope protein structure revealed several hypoth

37 in are structurally homologous to eukaryotic virus envelope proteins, suggesting that Archaea and vir

38 ns and conformational changes of specialized virus envelope proteins termed membrane fusion proteins.

39 tophan 142 being an essential residue on the virus envelope protein that interacts directly with the

40 for activity in preventing binding of dengue virus envelope protein to immobilized heparin; compounds

41 A PCP-consensus protein of a Dengue virus envelope protein was produced recombinantly and te

42 ed Notch signaling in MEG-01 cells where the virus envelope protein was shown to interact with TAL-1,

43 on virions pseudotyped with murine leukemia virus envelope protein was similar to that on particles

44 a recombinant chimeric form of dengue type 2 virus envelope protein was used as a probe to investigat

45 athways are needed for trafficking of insect virus envelope proteins, we engineered a Drosophila mela

46 pseudovirions displaying distinct influenza virus envelope proteins were tested for fusion activity.

47 ined the function of Moloney murine leukemia virus envelope proteins with substitutions in the membra

48 We have examined mutant Rous sarcoma virus envelope proteins with truncations or deletions wi